Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in China - Full Text View

Sponsored by:	Wyeth
Information provided by:	Wyeth
ClinicalTrials.gov Identifier:	NCT00478829

Purpose

Objectives: Primary: To estimate the prevalence of depression and/or anxiety disorder in outpatients attending the general health care settings in China.

Secondary:

To estimate gender- and age-specific prevalence of depression and/or anxiety disorder in outpatients attending the general health care settings in China.
To estimate the prevalence of depression and/or anxiety disorder in outpatients attending the general health care settings such as departments of neurology, gastroenterology, cardiology, and gynecology.
To describe the recognition and treatment rate by treating physicians as depression and/or anxiety for outpatients in the general health care settings in China.

Condition
Adult

MedlinePlus related topics: Anxiety Depression

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective
Official Title:	Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in 5 Large Cities in China

Further study details as provided by Wyeth:

Estimated Enrollment:	8000
Study Start Date:	April 2007
Study Completion Date:	July 2007

Detailed Description:

This study is designed to investigate the status of identifying depression and/or anxiety disorder with somatic symptoms in general hospitals in China.

The study will generate valuable information to the medical community; therefore the early and vigorous treatment is possible. It's in line with China government authorities' target to increase the recognition rate of depression and/or anxiety in primary care settings to more than 50% by the end of 2010. The study will also help to identify specific diagnosis and treatment patterns for depressive / anxious patients and their comorbid conditions.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Main Inclusion Criteria:

Greater than or equal to 18 years.
Consecutive general internal medical outpatients attending the selected general hospitals in the investigate days(Department of neurology, gastrointestinal, cardiology and gynecology).
Informed consent obtained for all patients who will undergo a standardized diagnostic assessment by specialized psychiatrists.

Main Exclusion Criteria:

Patients who have been screened on a previous visit.
Patients who are unable to complete the survey because of mental or physical incapacity.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00478829

Locations

China

Beijing, China, 100730

Beijing, China, 100034

Beijing, China, 100044

Shanghai, China, 200025

Shanghai, China, 200233

Shanghai, China, 200235
China, Guangdong

Guangzhou, Guangdong, China, 510120

Guangzhou, Guangdong, China, 510180

Guangzhou, Guangdong, China, 510630
China, Hunan

Changsha, Hunan, China, 410011

Changsha, Hunan, China, 410013

Changsha, Hunan, China, 410008
China, Sichuan

Chengdu, Sichuan, China, 610041

Chengdu, Sichuan, China, 610072

Chengdu, Sichuan, China, 610083

Sponsors and Collaborators

Wyeth

Investigators

Study Director:	Medical Monitor	Wyeth
Principal Investigator:	Trial Manager	For China, medinfo@wyeth.com

More Information

No publications provided

Study ID Numbers:	0600B2-4417
Study First Received:	May 24, 2007
Last Updated:	December 4, 2007
ClinicalTrials.gov Identifier:	NCT00478829 History of Changes
Health Authority:	China: State Food and Drug Administration

Study placed in the following topic categories:

Depression
Depressive Disorder

ClinicalTrials.gov processed this record on May 07, 2009